Evommune (EVMN) Cash & Equivalents (2024 - 2026)
Evommune (EVMN) reported Cash & Equivalents of $48.3 million for Q1 2026, up 747.09% year-over-year from $5.7 million in Q1 2025, and up 9.66% quarter-over-quarter from $44.1 million in Q4 2025.
Evommune (EVMN) Cash & Equivalents (2024 - 2026) Analysis & Trends
Evommune (EVMN) has 3 years of Cash & Equivalents data on file, last reported at $48.3 million in Q1 2026.
- Cash & Equivalents for Q1 2026 came in at $48.3 million, up 747.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $48.3 million (up 747.09% YoY), and the FY2025 annual result was $44.1 million, up 171.07% from the prior year.
- Cash & Equivalents rose to $48.3 million in Q1 2026 per EVMN's latest filing, from $44.1 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $48.3 million in Q1 2026 and troughed at $5.7 million in Q1 2025.
- A 3-year average of $26.6 million and a median of $22.5 million in 2024 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2025 and 2026: Cash & Equivalents jumped 47.79% in 2025, then soared 747.09% in 2026.
- A 3-year view of Cash & Equivalents shows it stood at $16.3 million in 2024, then surged by 171.07% to $44.1 million in 2025, then advanced by 9.66% to $48.3 million in 2026.
- Business Quant data shows EVMN's Cash & Equivalents at $48.3 million in Q1 2026, $44.1 million in Q4 2025, and $26.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 1.91 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 2.77 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 18.44 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 7.15 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 5.49 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 558.94 Mn |
| 10 | Evommune | 680.81 Mn | 469.35 Mn | - | 48.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.32 Mn |
| Dec 31, 2025 | 44.06 Mn |
| Sep 30, 2025 | 26.82 Mn |
| Mar 31, 2025 | 5.70 Mn |
| Dec 31, 2024 | 16.26 Mn |
| Sep 30, 2024 | 18.15 Mn |